CHARACTERIZATION OF HUMANIZED ANTI-P185HER2 ANTIBODY FAB FRAGMENTS PRODUCED IN ESCHERICHIA-COLI

被引:0
|
作者
KELLEY, RF
OCONNELL, MP
CARTER, P
PRESTA, L
EIGENBROT, C
COVARRUBIAS, M
SNEDECOR, B
SPECKART, R
BLANK, G
VETTERLEIN, D
KOTTS, C
机构
[1] GENENTECH INC, DEPT FERMENTAT, San Francisco, CA 94080 USA
[2] GENENTECH INC, DEPT PROC SCI, San Francisco, CA 94080 USA
[3] GENENTECH INC, DEPT MED & ANALYT CHEM, San Francisco, CA 94080 USA
来源
ACS SYMPOSIUM SERIES | 1993年 / 526卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We have been using biochemical and biophysical methods to characterize chimeric and humanized variants of the murine monoclonal antibody 4D5, directed against human epidermal growth factor receptor 2 (p185HER2). These studies were performed on antibody Fab fragments produced by secretion from E. coli. Humanized Fab fragment (hu4D5-8 Fab) was expressed at very high levels (1-2 g/L), whereas chimeric Fab (ch4D5 Fab) was expressed at much lower titers (5-20 mg/L), as determined by antigen-binding ELISA of supernatants from 10 L fermentations. Hu4D5-8 Fab and ch4D5 Fab purified by using affinity chromatography on immobilized bacterial IgG-binding proteins gave identical far UV-CD spectra characteristic of the immunoglobulin fold. Thermodynamic studies of antigen binding show comparable affinities (DELTAG) for ch and hu4D5-8 Fab, but different DELTAH values suggesting slight differences in the mechanism of binding. This difference is reflected in the anti-proliferative activity of these fragments on human breast tumor cells.
引用
收藏
页码:218 / 239
页数:22
相关论文
共 50 条
  • [21] PURIFICATION AND CHARACTERIZATION OF RECOMBINANT HUMAN INTERLEUKIN-2 PRODUCED IN ESCHERICHIA-COLI
    KATO, K
    YAMADA, T
    KAWAHARA, K
    ONDA, H
    ASANO, T
    SUGINO, H
    KAKINUMA, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 130 (02) : 692 - 699
  • [22] CHARACTERIZATION OF P-SATIVUM CHLOROPLAST PSBA TRANSCRIPTS PRODUCED INVIVO, INVITRO AND IN ESCHERICHIA-COLI
    BOYER, SK
    MULLET, JE
    PLANT MOLECULAR BIOLOGY, 1986, 6 (04) : 229 - 243
  • [23] Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast
    Baselga, J
    Tripathy, D
    Mendelsohn, J
    Baughman, S
    Benz, CC
    Dantis, L
    Sklarin, NT
    Seidman, AD
    Hudis, CA
    Moore, J
    Rosen, PP
    Twaddell, T
    Henderson, IC
    Norton, L
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) : 737 - 744
  • [24] ENGINEERING HIGH-AFFINITY HUMANIZED ANTI-P185(HER2)/ANTI-CD3 BISPECIFIC F(AB')(2) FOR EFFICIENT LYSIS OF P185(HER2) OVEREXPRESSING TUMOR-CELLS
    ZHU, ZP
    LEWIS, GD
    CARTER, P
    INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (03) : 319 - 324
  • [25] IN-VIVO BIOTINYLATED RECOMBINANT ANTIBODIES - CONSTRUCTION, CHARACTERIZATION, AND APPLICATION OF A BIFUNCTIONAL FAB-BCCP FUSION PROTEIN PRODUCED IN ESCHERICHIA-COLI
    WEISS, E
    CHATELLIER, J
    ORFANOUDAKIS, G
    PROTEIN EXPRESSION AND PURIFICATION, 1994, 5 (05) : 509 - 517
  • [26] Treatment of meningeal breast cancer xenografts in the rat using an anti-P185/HER2 antibody
    Bergman, I
    Barmada, MA
    Griffin, JA
    Slamon, DJ
    CLINICAL CANCER RESEARCH, 2001, 7 (07) : 2050 - 2056
  • [27] Comparison of the antiplatelet agent potential of the whole molecule, F(ab')(2) and Fab fragments of humanized anti-GPIIb/IIIa monoclonal antibody in monkeys
    Kaku, S
    Yano, S
    Kawasaki, T
    Sakai, Y
    Suzuki, K
    Kawamura, K
    Masuho, Y
    Satoh, N
    Takenaka, T
    Landolfi, NF
    Co, MS
    GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1996, 27 (03): : 435 - 439
  • [28] Extracellular production of an anti-HER2 single-chain variable antibody fragment in Escherichia coli
    Hyun, Jae-Won
    Lee, Kibin
    Kim, Ji-Hun
    Sim, Dae-Won
    Byun, Kyu-Tae
    Jung, Seung-Jae
    Paeng, Jin Chul
    Kang, Tae-Bong
    Park, Jooho
    Kim, Chan-Gil
    Won, Hyung-Sik
    PROCESS BIOCHEMISTRY, 2021, 111 : 87 - 94
  • [29] AHNP-streptavidin:: a tetrameric bacterially produced antibody surrogate fusion protein against p185her2/neu
    Masuda, K.
    Richter, M.
    Song, X.
    Berezov, A.
    Masuda, K.
    Murali, R.
    Greene, M. I.
    Zhang, H.
    ONCOGENE, 2006, 25 (59) : 7740 - 7746
  • [30] AHNP-streptavidin: a tetrameric bacterially produced antibody surrogate fusion protein against p185her2/neu
    K Masuda
    M Richter
    X Song
    A Berezov
    K Masuda
    R Murali
    M I Greene
    H Zhang
    Oncogene, 2006, 25 : 7740 - 7746